Here is a question we hear almost every week at our Manhattan locations: "Just give me Botox — the regular kind." What most clients don't realize is that Botox, Dysport, and Xeomin are all versions of the same core molecule — botulinum toxin type A — and choosing the right one isn't about brand loyalty. It's about understanding how subtle differences in formulation, diffusion behavior, onset time, and unit dosing translate to real differences in how your face looks and feels after treatment. In 2026, with all three neuromodulators firmly established in the market and a growing body of real-world clinical experience behind them, injectors have more nuance and precision at their disposal than ever before. This guide cuts through the brand noise to give you a clinically grounded, experience-informed breakdown of each product — so you can walk into your next consultation knowing exactly what questions to ask.
What Are Neuromodulators, and Why Does the Brand Actually Matter?
All three products — Botox, Dysport, and Xeomin — work by temporarily blocking the nerve signals that cause muscles to contract. No signal means no contraction, which means dynamic wrinkles (the kind caused by repeated facial movement) soften or disappear. The core ingredient in all three is the same: botulinum toxin type A, produced by the bacterium Clostridium botulinum. So why does brand matter at all?
The answer lies in formulation. Each manufacturer produces their neuromodulator using a different purification process, with different accessory proteins (or none at all), different protein loads, and different molecular structures that affect how the toxin behaves once it's injected into tissue. These aren't cosmetic differences — they directly influence diffusion radius, onset timing, effective dose, and even how your immune system responds over repeated treatments.
The Core Science: Same Mechanism, Different Behavior
Botulinum toxin type A works at the neuromuscular junction. When injected, it is absorbed into the nerve terminal and cleaves a protein called SNAP-25, which is essential for releasing acetylcholine — the neurotransmitter that tells muscles to contract. Without acetylcholine release, the muscle simply doesn't fire. The wrinkle-causing movement stops, and over time, the overlying skin smooths out.
What differs between products is not this core mechanism but rather:
- Protein complexing: Botox (onabotulinumtoxinA) and Dysport (abobotulinumtoxinA) are both complexed with accessory proteins, though in different amounts and configurations. Xeomin (incobotulinumtoxinA) is "naked" — it contains no accessory proteins whatsoever.
- Unit equivalency: The unit systems are not interchangeable. Roughly speaking, 1 unit of Botox is approximately equivalent to 2.5–3 units of Dysport, though conversion ratios vary by injection site and individual response. Xeomin and Botox are closer to a 1:1 ratio, though this too varies.
- Diffusion radius: Dysport's formulation means it tends to spread slightly further from the injection point — which can be an advantage in some treatment areas and a liability in others.
- Storage requirements: Xeomin's lack of accessory proteins means it does not require refrigeration before reconstitution — a minor logistical advantage for practices.
Understanding these differences is what separates a good injection outcome from a great one. An experienced injector doesn't just choose a product arbitrarily — they choose based on treatment area, client anatomy, desired result, and the product's specific behavioral profile.
Botox in 2026: Still the Gold Standard — But for Specific Reasons
Botox (onabotulinumtoxinA), manufactured by Allergan Aesthetics (now part of AbbVie), remains the most prescribed neuromodulator in the United States. Its dominance isn't just brand recognition — it reflects decades of accumulated clinical data, the widest range of FDA-approved indications, and a highly consistent, predictable performance profile that injectors can rely on.
What Makes Botox Distinctively Reliable
Botox was the first botulinum toxin type A product approved by the FDA for cosmetic use, and it has accumulated more peer-reviewed research and long-term safety data than any other neuromodulator on the market. For injectors, this means that dosing guidelines are extremely well-established. The "Allergan unit" has become the de facto standard against which all other products are measured.
In terms of behavior, Botox has what most injectors describe as a contained diffusion profile — it tends to stay relatively close to the injection point. This makes it the preferred choice for areas requiring precision: the crow's feet region around the eyes, the lip border (for lip flip procedures), the platysmal bands of the neck, and anywhere that inadvertent spread could affect an unintended muscle group. For example, in the area around the brow, unwanted diffusion can cause ptosis (drooping), so a product with more controlled spread is generally preferred by cautious injectors.
Onset, Duration, and Who It's Best For
Botox typically begins showing results within 3–7 days after injection, with full effect visible around the two-week mark. Duration averages 3–4 months for most clients, though this varies significantly based on metabolic rate, treatment area, dosage, and whether the client is a first-timer or has been receiving regular treatments for years (long-term clients often find their results last longer as the treated muscles gradually weaken from disuse).
Botox tends to be the preferred starting point for:
- First-time neuromodulator clients who want a well-studied, predictable product
- Clients seeking precision treatment around the eyes, lips, or brow
- Those with complex facial anatomy where controlled diffusion is critical
- Clients who have had good experiences with Botox in the past and want to maintain consistency
At our Union Square and Midtown East locations, we often see clients who've been on Botox for years — many of whom have never questioned the product because their results have been consistently excellent. That's not brand inertia; that's the product doing what it's designed to do. That said, there are specific scenarios where Dysport or Xeomin may outperform Botox — and that's where the conversation gets interesting.
Dysport: The Faster-Spreading Option That Excels in the Right Hands
Dysport (abobotulinumtoxinA), manufactured by Galderma, has been available in the US market since 2009 and has a longer history of use in Europe and parts of Asia. It is a genuinely distinct formulation — not just a "generic" version of Botox — and its behavioral differences are clinically meaningful when applied correctly.
The Diffusion Advantage (and Why It Requires Skill)
The most frequently discussed characteristic of Dysport is its tendency to diffuse more broadly from the injection site compared to Botox. The accessory protein structure and molecular weight of Dysport contribute to a slightly larger effective radius. In clinical practice, this means that fewer injection points may be needed to cover a given treatment area — which can reduce discomfort and treatment time.
Where this diffusion advantage really shines is in large, flat muscle groups — most notably the forehead. The frontalis muscle spans the entire width of the forehead, and achieving smooth, even relaxation across this broad surface can require many injection points with Botox. Dysport's broader spread allows skilled injectors to cover the same area with fewer punctures while achieving a more uniformly smooth result. Many experienced injectors specifically prefer Dysport for forehead treatment for exactly this reason.
However — and this is critical — that same diffusion behavior becomes a liability in areas where precision is paramount. Around the eyes, the brow, and the perioral region, a product that spreads too freely risks affecting adjacent muscle groups that shouldn't be relaxed. This is why Dysport is rarely the first choice for crow's feet or lip flip procedures in clinically conservative practices.
Faster Onset: A Real Clinical Difference
Dysport consistently shows a faster onset than Botox across clinical experience and practitioner observation. Many clients report seeing initial results within 24–48 hours, with full effect typically visible within 7–10 days. For clients who have an upcoming event and want to see results quickly, this can be a meaningful advantage. It's one of the reasons our injectors sometimes discuss Dysport specifically with clients who come in close to a special occasion and want the fastest possible turnaround.
Dysport and the "Heavy Forehead" Problem
One nuanced clinical scenario where Dysport frequently outperforms: clients who describe feeling a "heavy" or "frozen" sensation in the forehead after Botox treatments. This sensation — more common in clients who receive higher doses to address strong frontalis muscles — can sometimes be mitigated by switching to Dysport and adjusting dosing, allowing for a more natural, slightly more mobile result while still softening the lines. This isn't universally true, but it's a pattern our clinical team has observed frequently enough that it informs our product recommendations during consultations.
Xeomin: The "Pure" Neuromodulator and What That Actually Means
Xeomin (incobotulinumtoxinA), manufactured by Merz Aesthetics, is sometimes described as the "naked" botulinum toxin — and that description is clinically accurate. Xeomin is the only FDA-approved neuromodulator that contains no accessory proteins. The purification process removes all complexing proteins, leaving only the active botulinum toxin molecule itself.
Why Protein-Free Matters: The Antibody Resistance Question
This is where Xeomin makes its most compelling clinical argument. When the immune system is repeatedly exposed to foreign proteins — which happens every time a traditional neuromodulator is injected — there is a theoretical risk of developing neutralizing antibodies. These antibodies don't target the toxin itself but rather the accessory proteins. Over time, in some patients, this immune response can reduce the effectiveness of the treatment — a phenomenon sometimes called "secondary non-response."
Because Xeomin contains no accessory proteins, FDA-cleared for cosmetic use since 2011, the immune system has fewer foreign protein targets to react to. For clients who have been receiving neuromodulator treatments for many years and have started noticing diminishing returns — requiring more frequent injections or higher doses to achieve the same result — Xeomin is often the first alternative worth exploring.
It's important to note that antibody resistance to neuromodulators is not common in the broader population of cosmetic clients, and the clinical significance at cosmetic (rather than therapeutic) doses is still a matter of ongoing professional discussion. But for long-term, high-frequency users, it's a real consideration that warrants a conversation with your injector.
Xeomin's Clinical Behavior: Precision Without Complexity
In terms of diffusion and onset, Xeomin behaves most similarly to Botox — relatively contained spread, onset within 3–7 days, and comparable duration. Many injectors who are experienced with both products use them almost interchangeably in precision areas, though individual client response always varies.
Where Xeomin has carved out a particularly strong niche is in clients with:
- A documented history of reduced response to Botox over time
- Concerns about long-term immune sensitization from repeated treatments
- Preference for a formulation with the minimal possible protein load
- Glabellar lines (the "11s" between the brows) — one of Xeomin's primary FDA-approved cosmetic indications
The Storage Advantage and What It Means for Product Quality
Because Xeomin lacks the accessory proteins that require refrigeration for stability, it can be stored at room temperature before reconstitution. While this is primarily a logistics advantage for clinical practices, it does have an indirect benefit for clients: Xeomin is less susceptible to quality degradation from cold chain disruptions during shipping and storage. In a well-run clinical environment this rarely matters, but it's a point of differentiation worth knowing.
Side-by-Side Comparison: Botox vs. Dysport vs. Xeomin
Rather than offering vague generalizations, the table below synthesizes the key clinical differentiators across all three products based on established formulation science, FDA labeling, and the collective clinical experience of our injection team across seven locations.
| Characteristic | Botox (Ona) | Dysport (Abo) | Xeomin (Inco) |
|---|---|---|---|
| Manufacturer | Allergan / AbbVie | Galderma | Merz Aesthetics |
| Accessory Proteins | Yes | Yes (different structure) | No ("naked" toxin) |
| Onset Time | 3–7 days | 1–3 days (faster) | 3–7 days |
| Full Effect | ~2 weeks | ~7–10 days | ~2 weeks |
| Duration | 3–4 months | 3–4 months | 3–4 months |
| Diffusion Radius | Moderate / Controlled | Broader spread | Moderate / Controlled |
| Unit System | Allergan Units (reference) | ~2.5–3x Botox units | ~1:1 with Botox |
| Best Areas | Crow's feet, lips, brow, forehead, neck | Forehead, large muscle groups | Glabella, long-term users, precision areas |
| Antibody Risk Mitigation | Standard | Standard | Theoretically lower |
| FDA Cosmetic Approval | Yes (multiple indications) | Yes | Yes |
| Pre-Reconstitution Storage | Refrigerated | Refrigerated | Room temperature |
Treatment Area Decision Framework: Which Product for Which Part of Your Face?
The most practical way to think about neuromodulator selection isn't as a global brand preference but as an area-by-area clinical decision. Different parts of the face have different muscle architecture, different movement patterns, and different risk profiles for inadvertent diffusion. Here is how our injection team thinks about product selection by zone.
The Forehead (Frontalis Muscle)
The forehead is one of the most requested treatment areas — and one of the most technically nuanced. The frontalis is a broad, thin muscle that elevates the brow. Overtreat it and you get the dreaded "frozen" look and brow ptosis. Undertreat it and horizontal lines persist.
Best suited for: Dysport (for its broader diffusion achieving even relaxation across the full width) or Botox (for clients who want precise, conservative dosing). Xeomin is a strong option for long-term forehead clients who have noticed diminishing Botox response.
Key consideration: The forehead cannot be treated in isolation without considering the brow position. Injectors must assess the balance between the frontalis (brow elevator) and the corrugators/procerus (brow depressors). Treating one without accounting for the other is how brow drop happens.
The Glabella ("11 Lines" Between the Brows)
The glabella region — targeted by the corrugator supercilii and procerus muscles — is the most common starting point for neuromodulator treatment and the primary FDA-approved cosmetic indication for all three products.
Best suited for: All three products perform well here. Botox and Xeomin are particularly well-studied in this area. For clients with very strong corrugator muscles (a common finding in clients who've spent years squinting at screens — something we see constantly in our NYC tech and finance clientele), higher doses may be needed, and Dysport's broader spread can sometimes provide more complete relaxation with fewer injection points.
Crow's Feet (Orbicularis Oculi)
The lateral orbital lines that fan out from the outer corners of the eyes require precision above all else. The orbicularis oculi is a circular muscle surrounding the eye, and inadvertent diffusion toward the lower eyelid or cheek can cause drooping or affect smile symmetry.
Best suited for: Botox or Xeomin. The controlled diffusion profile of both products makes them the safer choice in this delicate periorbital zone. Dysport is generally not the first choice here, particularly for clients with thinner orbital tissue or a history of eyelid concerns.
The Lip Flip
The lip flip — injecting small amounts of neuromodulator into the orbicularis oris to gently evert the upper lip — has surged in popularity as a subtle, non-filler way to add lip definition. It requires extremely precise, minimal-dose placement.
Best suited for: Botox, almost universally. The precision requirements and the risk of affecting the muscles needed for speech, drinking, and kissing make this the last place you want broad diffusion. Our injectors consistently prefer Botox for lip flip procedures across all our Manhattan and Miami locations.
The Neck (Platysmal Bands and Nefertiti Lift)
Neuromodulator treatment of the neck — either to soften the vertical platysmal bands or to achieve the "Nefertiti lift" effect by releasing the downward pull of the platysma on the lower face — requires careful dosing because the neck muscles are thinner and more diffuse than facial muscles.
Best suited for: Botox for its predictability in this area. Dysport can be used by experienced injectors who are comfortable with its diffusion characteristics in the neck region. This is generally not a first-treatment area — it's best reserved for clients who have an established relationship with their injector and have already optimized their facial neuromodulator protocol.
Masseter / Jaw Slimming
Masseter reduction — using neuromodulators to relax the large chewing muscle at the angle of the jaw — has become one of the most requested treatments at our locations, particularly among clients seeking facial slimming and TMJ relief.
Best suited for: Botox or Dysport. Because the masseter is a large, powerful muscle, higher doses are typically required, and Dysport's unit-to-unit cost efficiency at higher volumes can make it a cost-effective option. Dosing must be calibrated carefully to avoid affecting nearby muscles involved in chewing and speaking.
The "Resistance" Conversation: What Happens When Botox Stops Working?
One of the most anxiety-inducing conversations in aesthetic medicine is when a long-term client says their Botox "isn't working like it used to." This phenomenon — sometimes called neuromodulator resistance or secondary non-response — is real, but it's frequently misattributed and misunderstood.
True Resistance vs. Technique and Dosing Issues
Before concluding that a client has developed antibody resistance, any competent injector should first rule out more common explanations:
- Underdosing: As clients age, muscle mass changes, and the dose that worked at 35 may not be sufficient at 45. Some injectors are conservative with dosing for new clients and never adjust upward as needs change.
- Technique drift: If a client has changed providers, differences in injection depth, placement, and reconstitution dilution can produce different results even with the same product.
- Reconstitution variation: The saline dilution used when preparing neuromodulators affects concentration and spread. Practices vary in their reconstitution protocols, and a more dilute preparation spreads further but may feel less potent.
- Metabolism changes: High-intensity exercise, certain medications, and metabolic changes can affect how quickly the body processes neuromodulators.
True immunological resistance — where the body produces neutralizing antibodies that deactivate the toxin — is relatively uncommon at cosmetic doses but does occur, particularly in clients who have been treated at very high doses or very high frequency over many years. When genuine resistance is suspected, switching to Xeomin is the most evidence-supported clinical strategy, precisely because its protein-free formulation removes the accessory protein targets that antibodies typically react to.
The Rotation Strategy
Some experienced injectors advocate for periodic rotation between neuromodulator products — not because any one product is superior, but as a strategy to minimize the cumulative protein exposure that could theoretically contribute to sensitization over time. There is no universal clinical consensus on whether this is necessary for cosmetic clients at standard doses, but it is a reasonable conversation to have with your provider if you are a high-frequency, long-term user.
What to Expect: The Treatment Experience From Consultation to Results
Understanding what actually happens during a neuromodulator treatment — and what to expect in the days and weeks after — helps set realistic expectations and ensures you're prepared to care for your skin appropriately.
The Consultation: This Step Is Non-Negotiable
A proper neuromodulator consultation involves more than pointing at your forehead and saying "fix this." At Skin Spa New York, our injectors conduct a comprehensive facial assessment before recommending any product or treatment plan. This includes:
- Dynamic muscle assessment — watching how your face moves during animation to identify which muscles are driving which lines
- Resting anatomy evaluation — assessing brow position, eyelid height, and facial symmetry at rest
- Skin quality assessment — considering skin thickness, elasticity, and the degree to which lines are dynamic (movement-caused) vs. static (present even at rest)
- Treatment history review — understanding what products you've used before, at what doses, and with what results
- Goal alignment — distinguishing between clients who want full relaxation vs. those who want subtle softening while maintaining natural movement
This assessment directly informs which product is recommended and how it's placed. Skipping this step — going to a provider who simply injects without assessment — is one of the most common sources of unsatisfying neuromodulator outcomes.
The Injection Process
Neuromodulator injections are quick — typically 10–20 minutes for a standard treatment — and involve minimal discomfort. The needles used are extremely fine (typically 30–32 gauge), and most clients describe the sensation as a small pinch at each injection point. Topical numbing cream can be applied beforehand for clients with lower pain tolerance, though many clients find it unnecessary.
After injection, you may notice small raised bumps at injection sites that resolve within 20–30 minutes. Mild redness and occasional minor bruising can occur — this is more likely around the eye area and in clients who take blood thinners, fish oil, or high-dose vitamin E. We advise clients to avoid alcohol for 24 hours before treatment to minimize bruising risk.
The Post-Treatment Window: What Not to Do
The first 4 hours after neuromodulator injection are the most critical for ensuring the product settles correctly. Our standard post-care guidance includes:
- Remain upright for at least 4 hours — no lying down or bending forward significantly
- Avoid rubbing or massaging the treated areas
- Skip intense exercise for 24 hours (increased blood flow can potentially disperse the product before it fully binds)
- Avoid facials, facial massage, and heat treatments (sauna, steam room) for 24–48 hours
- Do not apply pressure to treated areas — including certain sleeping positions if you're a side sleeper
Results begin appearing within 24–72 hours for Dysport and 3–7 days for Botox and Xeomin. We always schedule a complimentary two-week follow-up to assess results and perform any minor touch-up injections if needed — a step that's particularly important for first-time clients whose muscle response can be difficult to predict precisely.
Pricing, Value, and How Not to Get Misled by "Cheap Botox"
Neuromodulator pricing is one of the most confusing aspects of the injectable market, largely because practices price their services in fundamentally different ways. Understanding the distinction is essential for making an informed decision — and for protecting yourself from potentially unsafe care.
Per-Unit vs. Per-Area Pricing
Per-unit pricing charges you for each unit of neuromodulator injected. This is more transparent because you know exactly what you're receiving. A typical forehead treatment might require 10–20 units of Botox, the glabella might require 15–25 units, and crow's feet 10–15 units per side. Per-unit prices in major metropolitan markets like New York and Miami typically reflect the premium of operating in high-cost environments, though pricing varies widely by provider type and location.
Per-area pricing charges a flat fee per treatment zone regardless of how many units are used. This can seem simpler, but it creates a misaligned incentive: the practice benefits financially from using fewer units, which can lead to systematic underdosing.
When evaluating pricing, the question to ask is not "what is the per-unit price?" but rather "how many units are you planning to use and why?" A credible injector should be able to answer this specifically based on your anatomy and treatment goals.
The "Cheap Botox" Warning
Significantly below-market pricing for neuromodulators is a genuine safety red flag. Botox, Dysport, and Xeomin are purchased by licensed providers directly from authorized distributors at established wholesale prices. If a practice is offering prices that seem impossibly low, one of several things may be happening:
- The product is over-diluted (more saline, less toxin per unit)
- The product is counterfeit or sourced from unauthorized distributors
- Doses are being systematically reduced without client awareness
- The injector is unlicensed or inadequately trained
In 2026, the FDA continues to warn consumers about counterfeit botulinum toxin products entering the market through unauthorized channels. Always confirm that your provider is a licensed medical professional purchasing product through legitimate supply chains. Asking to see the product vial before injection is entirely reasonable and any reputable provider will accommodate this request.
Combining Neuromodulators With Other Treatments: The "GlowTox" Approach
In 2026, neuromodulators are rarely used in isolation at sophisticated med spas. The most meaningful aesthetic results come from combining neuromodulators with complementary treatments that address the full spectrum of aging — not just muscle movement, but skin quality, volume loss, and texture.
Neuromodulators + Dermal Fillers
This is the classic combination. Neuromodulators address dynamic wrinkles caused by muscle movement; dermal fillers (Juvéderm, Restylane) address volume loss and static lines that exist even when the face is at rest. Together, they address complementary aspects of facial aging that neither treatment can fully address alone. The "liquid facelift" concept — using strategic combinations of neuromodulators and fillers to lift, volumize, and smooth — is one of the most requested treatment approaches at our Manhattan locations.
Neuromodulators + Skin Resurfacing
Pairing neuromodulators with treatments like Morpheus8, Laser Genesis, or Lumecca IPL creates a powerful two-pronged approach: the neuromodulator prevents the muscle movement that causes new lines to form, while the resurfacing treatment improves the quality, texture, and tone of the overlying skin. Clients who combine these treatments consistently report more comprehensive results than either treatment alone provides.
Timing matters here. Most injectors recommend completing neuromodulator treatment first and waiting at least two weeks before performing resurfacing procedures in the same area — or doing them in the correct sequence at your consultation.
The HydraFacial + Neuromodulator Protocol
One combination we see clients requesting increasingly often is HydraFacial followed by neuromodulator injection on the same visit. This is generally safe as long as the HydraFacial is performed before injection — not after, as the suction and massage components of HydraFacial could theoretically disperse freshly placed neuromodulator. Pre-injection HydraFacial preps the skin and ensures it's at its best condition when the injector assesses anatomy for treatment planning.
Who Is — and Isn't — a Good Candidate for Neuromodulator Treatment?
Neuromodulators are among the most broadly appropriate cosmetic treatments available, but they are not right for everyone, and a proper candidacy assessment is an essential part of responsible practice.
Good Candidates
You are generally a strong candidate for neuromodulator treatment if you:
- Have dynamic wrinkles — lines that appear or deepen with facial expression
- Are in good general health with no relevant neuromuscular conditions
- Have realistic expectations — understanding that results are temporary and require maintenance
- Are not pregnant or breastfeeding
- Are not allergic to botulinum toxin or any product ingredients (including human albumin, which is present in Botox and Dysport formulations)
- Do not have an active skin infection or inflammation at the planned injection sites
Clients Who Should Proceed With Caution or Defer
Certain conditions require careful evaluation before proceeding:
- Neuromuscular disorders (myasthenia gravis, Lambert-Eaton syndrome, ALS) — neuromodulators can potentiate muscle weakness in these conditions and should only be considered under direct physician oversight
- Clients on aminoglycoside antibiotics — these can enhance the effect of botulinum toxin and may increase risk of over-relaxation
- Clients with significant brow ptosis at baseline — if the brow is already low-set, relaxing the frontalis can worsen this appearance
- Clients with very deep static lines — lines that are present even at full rest may not respond meaningfully to neuromodulators alone; fillers or resurfacing may be more appropriate
If you are experiencing any of the above conditions, we strongly recommend a consultation with a board-certified dermatologist or plastic surgeon before pursuing neuromodulator treatment. Our medical director reviews complex candidacy cases at Skin Spa New York to ensure every client receives a treatment plan appropriate to their individual health profile.
How to Choose the Right Provider: Beyond the Product Brand
Here is a truth the industry doesn't always advertise loudly enough: the injector matters more than the brand. Botox in the hands of an inexperienced injector will produce inferior results compared to Dysport or Xeomin in the hands of a skilled, anatomically fluent clinician. The product is a tool; the outcome depends on the person wielding it.
Credentials to Look For
In the United States, neuromodulator injections should be performed by — or under the direct supervision of — a licensed medical professional. Depending on your state, this may include:
- Physicians (MD or DO)
- Nurse practitioners (NP or DNP)
- Physician assistants (PA-C)
- Registered nurses (RN) operating under physician oversight
Estheticians — even highly skilled ones — are not licensed to perform injections in any US state. If a practice is offering injectable treatments performed by estheticians without licensed medical oversight, this is a serious regulatory and safety concern.
Questions to Ask at Your Consultation
A confident, competent injector will welcome these questions:
- What is your specific training in facial anatomy and neuromodulator injection?
- Which product are you recommending for my treatment, and why?
- How many units are you planning to use, and in which specific locations?
- What is your policy if I'm not satisfied with my results at the two-week mark?
- Can I see before-and-after photos of your actual patients with similar anatomy to mine?
At Skin Spa New York, all neuromodulator injections are performed by our licensed nursing and nurse practitioner team, with protocols reviewed by our medical director, Daphne Duren, DNP. Our injectors undergo ongoing training in advanced injection techniques, facial anatomy, and product-specific administration — because the standard of care in this category should be advancing constantly, not static.
Frequently Asked Questions
Is Botox the same as Dysport and Xeomin?
They all contain botulinum toxin type A and work through the same mechanism, but they are distinct formulations with different accessory protein structures, unit systems, onset times, and diffusion profiles. They are not interchangeable on a unit-for-unit basis and behave differently in clinical practice.
Which neuromodulator lasts the longest?
All three products have comparable duration ranges — typically 3–4 months for most clients. No product has been definitively shown to outlast the others in well-designed clinical comparisons. Duration varies more significantly based on individual metabolism, dosage, and treatment area than by product brand.
Does Dysport spread too much? Is it safe?
Dysport does diffuse more broadly than Botox or Xeomin, but in the hands of an experienced injector, this characteristic is a clinical tool rather than a liability. It is FDA-approved, widely used, and safe when administered correctly. Its diffusion profile makes it particularly well-suited for large, flat muscle groups like the forehead.
Can I switch from Botox to Xeomin if Botox stops working?
Yes, and this is one of the most clinically supported reasons to consider switching. If you have been receiving Botox treatments for many years and notice diminishing effectiveness — requiring more frequent treatments or higher doses — a conversation about switching to Xeomin is worthwhile. Xeomin's protein-free formulation may help restore responsiveness in clients who have developed antibody-mediated resistance to complexed neuromodulators.
How many units of Botox do I need for my forehead?
This varies significantly based on your muscle strength, forehead size, and desired level of relaxation. A typical forehead treatment ranges from 10–30 units of Botox (or equivalent doses of Dysport or Xeomin). Your injector should assess your anatomy and explain their recommended dose at your consultation — anyone who quotes a number without examining you first is cutting corners.
Can men get Botox, Dysport, or Xeomin?
Absolutely. Neuromodulator treatments are increasingly popular among male clients, and dosing is often adjusted upward because men typically have stronger, more developed facial muscles. Our male grooming clients across Manhattan and Miami represent a growing segment of our injectable practice. The goals are often slightly different — men typically want softening rather than elimination of lines, preserving a natural, strong appearance.
How soon before an event should I get neuromodulator treatment?
We recommend scheduling at least two weeks before any major event. This allows full effect to develop and time for any necessary touch-up adjustments. For Dysport, one week may be sufficient given its faster onset, but two weeks remains the gold standard for all three products to ensure you're seeing the final, settled result before your event.
Does getting neuromodulators regularly make your face look frozen or unnatural?
Frozen or unnatural results are a product of overdosing and poor technique — not of regular treatment itself. In fact, many long-term neuromodulator clients find that their results become more refined over time as their injector develops a precise understanding of their anatomy and response. The goal of skilled injection is always preserved natural expression with softened lines.
Can I combine neuromodulators with fillers at the same appointment?
Yes, and this is a very common combination. Many clients receive both neuromodulators and dermal fillers at the same appointment, addressing muscle-driven lines and volume loss simultaneously. Your injector will typically place neuromodulators before fillers to avoid any interference from the filler placement affecting neuromodulator distribution.
What is the difference between Botox for cosmetic use and therapeutic use?
Botox was originally developed as a therapeutic medication and is FDA-approved for conditions including chronic migraine, hyperhidrosis (excessive sweating), cervical dystonia, overactive bladder, and more. The same molecule is used at different doses and injection sites for these indications. Cosmetic Botox uses the product specifically to address dynamic facial wrinkles at significantly lower doses than many therapeutic applications.
Is there an age that's "too young" or "too old" to start neuromodulator treatment?
There is no fixed age threshold. Treatment decisions should be based on anatomy, skin quality, and individual goals rather than chronological age. Some clients in their mid-to-late twenties benefit from early preventive treatment to slow the formation of lines; clients in their sixties and beyond can still achieve meaningful softening of dynamic wrinkles. An in-person assessment is always the most accurate way to determine whether treatment is appropriate and what it can realistically achieve for your specific skin.
How do I know which product my provider is using?
Always ask. Your injector should be able to tell you exactly which product they're using, the batch number if requested, and allow you to see the vial. If a practice is reluctant to disclose this information, that is a red flag. At Skin Spa New York, we are fully transparent about product selection and welcome questions about our clinical decision-making process.
The Bottom Line: Choosing Your Neuromodulator Is a Clinical Decision, Not a Brand Decision
After more than two decades of treating skin at Skin Spa New York — across seven Manhattan locations, our Boston practices, and our Miami Beach location — our clinical team has arrived at a consistent conclusion: the best neuromodulator is the one that's right for your specific anatomy, goals, and treatment history, administered by an injector who knows how to deploy its unique characteristics strategically.
Botox remains the most studied, most reliably precise option and an excellent starting point for most clients. Dysport offers a genuine advantage in broad treatment areas like the forehead, with faster onset for clients on a timeline. Xeomin is the thoughtful choice for long-term users concerned about resistance, and a strong performer in precision areas for clients seeking a protein-minimized formulation.
None of these products will give you a result better than the skill of your injector and the quality of your pre-treatment assessment. The conversation that matters most isn't "which brand should I ask for?" — it's the one you have in the treatment room, where your anatomy is actually being evaluated by someone who understands both the science and the art of facial injectable medicine.
If you're ready to have that conversation, book a consultation with our injection team at Skin Spa New York. Whether you're a first-time injectable client or a seasoned neuromodulator veteran looking to optimize your results, our licensed RN injectors and medical oversight team are equipped to give you a genuinely personalized treatment plan — not a one-size-fits-all brand recommendation.